K. E. Cherry

Preclinical Development Inhibition of PARP-1 by Olaparib ( AZD 2281 ) Increases the Radiosensitivity of a Lung Tumor Xenograft

B. Telfer, D. Hirst, I. Stratford, 2011 .

Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself

N. Curtin, B. Telfer, D. Hirst, 2015, PloS one.

Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft

B. Telfer, D. Hirst, M. O’Connor, 2011, Molecular Cancer Therapeutics.